Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting
| ETNHX Fund | USD 35.88 0.06 0.17% |
Slightly above 62% of Eventide Healthcare's investor base is looking to short. The analysis of overall sentiment of trading Eventide Healthcare Life mutual fund suggests that many investors are alarmed at this time. Eventide Healthcare's investing sentiment can be driven by a variety of factors including economic data, Eventide Healthcare's earnings reports, geopolitical events, and overall market trends.
Eventide |
Ziftomenib combined with 73 in 1L NPM1-m or KMT2A-r adverse risk AML patients selected for oral presentation on Saturday, December 7th Ziftomenib...
Read at globenewswire.com
 |
Eventide Healthcare Fundamental Analysis
We analyze Eventide Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eventide Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eventide Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Eventide Healthcare is currently under evaluation in price to sales among similar funds. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Eventide Healthcare Life Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eventide Healthcare mutual fund to make a market-neutral strategy. Peer analysis of Eventide Healthcare could also be used in its relative valuation, which is a method of valuing Eventide Healthcare by comparing valuation metrics with similar companies.
Peers
Eventide Healthcare Related Equities
| BFOCX | Berkshire Focus | 1.35 | ||||
| CPOAX | Morgan Stanley | 1.00 | ||||
| ETILX | Eventide Gilead | 0.27 | ||||
| ETGLX | Eventide Gilead | 0.26 | ||||
| ETIHX | Eventide Healthcare | 0.16 |
Other Information on Investing in Eventide Mutual Fund
Eventide Healthcare financial ratios help investors to determine whether Eventide Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eventide with respect to the benefits of owning Eventide Healthcare security.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |